A recent study only fanned the fire of controversy surrounding
the estimated $4 billion spent each year by the drug industry on
direct-to-consumer advertising. Many advocates for public health
have complained about drug ads showing happy people whose lives
have been changed by a drug, which is where the study came into
play.
The study involved sending actors pretending to be patients complaining
of symptoms of stress and fatigue into 152 doctors' offices to see
whether they would be given prescriptions. (The physicians had previously
consented to participate but were not told when they would be tested.)
Researchers found that "patients"
were five times as likely to walk out of doctors' offices with
a prescription when they mentioned seeing an ad for the heavily
promoted antidepressant Paxil.
Moreover, when the "patients" asked for Paxil specifically,
55 percent were given prescriptions and 50 percent were diagnosed
with depression.
Concerns have recently mounted regarding the safety of antidepressants
after disclosures that the pharmaceutical industry withheld studies
that found the drugs were no better than sugar pills. Further, the
Food and Drug Administration concluded that antidepressant drugs
can lead to suicidal thinking and behavior among children and required
them to carry black-box warnings -- which have significantly reduced
direct-to-consumer advertising of such drugs.
Thoughts on the Issue
Critics claim results such as those highlighted in the study only
solidify the haphazard approach to health promotion that is driven
primarily by the pharmaceutical industry's interest in turning a
profit.
Further, one scientist and physician from the University of Washington
stated an overwhelming 80 percent of his peers feel the multitude
of drug ads that litter the print and broadcast media tempt patients,
more times than not, to ask for medications that aren't needed.
He also estimated only about 10 percent think drug ads are a good
thing.
President and chief executive of the Pharmaceutical Research and
Manufacturers of America (PhRMA) agreed that the organization could
do a much better job with the advertising.
Journal
of the American Medical Association April 27, 2005;293(16):1995-2002
Washington
Post April 27, 2005
|